Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Amazon
AMZN
|
$784M |
| 2 |
Netflix
NFLX
|
$762M |
| 3 |
Intuit
INTU
|
$712M |
| 4 |
Meta Platforms (Facebook)
META
|
$671M |
| 5 |
Uber
UBER
|
$635M |
Top Sells
| 1 |
Walmart
WMT
|
$1.16B |
| 2 |
Walt Disney
DIS
|
$920M |
| 3 |
Intel
INTC
|
$897M |
| 4 |
UnitedHealth
UNH
|
$781M |
| 5 |
Cisco
CSCO
|
$637M |
Sector Composition
| 1 | Technology | 30.01% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 10.13% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Veracyte
VCYT
$2.48B
| $48.2M | 0.03% |
1,169,618
+212,117
| +22% | +$8.74M |
|
227
Range Resources
RRC
$8.32B
| $47.3M | 0.03% |
2,651,836
+149,040
| +6% | +$2.66M |
|
|
UMPQ
228
DELISTED
Umpqua Holdings Corp
UMPQ
| $47M | 0.03% |
2,441,646
+3,001
| +0.1% | +$57.7K |
|
229
DexCom
DXCM
$31.7B
| $46.1M | 0.03% |
343,428
+127,096
| +59% | +$17.1M |
|
230
Nice
NICE
$8.56B
| $45.6M | 0.03% |
150,332
+189
| +0.1% | +$57.4K |
|
231
Ovintiv
OVV
$10.9B
| $45M | 0.03% |
+1,336,109
| New | +$45M |
|
232
iShares Core US Aggregate Bond ETF
AGG
$131B
| $44.7M | 0.03% |
392,060
+30,055
| +8% | +$3.43M |
|
|
PACW
233
DELISTED
PacWest Bancorp
PACW
| $44.4M | 0.02% |
983,803
-3,639
| -0.4% | -$164K |
|
234
Plexus
PLXS
$3.72B
| $44.4M | 0.02% |
462,609
-28,923
| -6% | -$2.77M |
|
235
CONMED
CNMD
$1.69B
| $44.1M | 0.02% |
311,007
-1,540
| -0.5% | -$218K |
|
236
Omnicell
OMCL
$1.52B
| $44M | 0.02% |
243,813
+4,093
| +2% | +$739K |
|
237
ENI
E
$52.5B
| $43.6M | 0.02% |
1,576,235
+598,297
| +61% | +$16.5M |
|
|
BPMC
238
DELISTED
Blueprint Medicines
BPMC
| $42.9M | 0.02% |
400,273
+84,615
| +27% | +$9.06M |
|
239
Natera
NTRA
$22.9B
| $42.5M | 0.02% |
455,473
+126,257
| +38% | +$11.8M |
|
240
Gerdau
GGB
$6.15B
| $42.2M | 0.02% |
10,798,495
+28,680
| +0.3% | +$112K |
|
241
Prestige Consumer Healthcare
PBH
$3.29B
| $42M | 0.02% |
691,918
-7,769
| -1% | -$471K |
|
242
Webster Financial
WBS
$10.5B
| $41.7M | 0.02% |
747,326
-13,732
| -2% | -$767K |
|
243
Integra LifeSciences
IART
$1.22B
| $40.3M | 0.02% |
602,051
-7,483
| -1% | -$501K |
|
244
Century Aluminum
CENX
$2.06B
| $39.9M | 0.02% |
2,410,791
+72,071
| +3% | +$1.19M |
|
|
MZTI
245
The Marzetti Company Common Stock
MZTI
$5.06B
| $39.9M | 0.02% |
240,827
-6,126
| -2% | -$1.01M |
|
|
NUVA
246
DELISTED
NuVasive, Inc.
NUVA
| $39.7M | 0.02% |
755,645
-6,908
| -0.9% | -$363K |
|
247
Honeywell
HON
$137B
| $38.9M | 0.02% |
186,654
+37,270
| +25% | +$7.77M |
|
248
ATI
ATI
$10.6B
| $38.1M | 0.02% |
2,391,431
-43,714
| -2% | -$696K |
|
249
Alcon
ALC
$39B
| $38M | 0.02% |
436,711
-35,671
| -8% | -$3.11M |
|
250
Halozyme
HALO
$8.59B
| $37.9M | 0.02% |
942,730
-62,708
| -6% | -$2.52M |
|